Overview
Soren Caffey is a Hematologist Oncology specialist and a Hematologist in Alexandria, Virginia. Dr. Caffey is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Anemia, Paget Disease of the Breast, Breast Cancer, and Deep Vein Thrombosis. Dr. Caffey is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8101 Hinson Farm Rd, Suite 211, Alexandria, VA 22306
University Of Maryland Oncology Associates PA
Taofeek Owonikoko is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Owonikoko is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Patrick Forde is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Forde is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.
Johns Hopkins University
Benjamin Levy is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Levy is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Caffey isDistinguished. Learn about Anemia.
- Breast CancerDr. Caffey isDistinguished. Learn about Breast Cancer.
- Deep Vein ThrombosisDr. Caffey isDistinguished. Learn about Deep Vein Thrombosis.
- Paget Disease of the BreastDr. Caffey isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Immune ThrombocytopeniaDr. Caffey isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Caffey isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Ampullary CancerDr. Caffey isAdvanced. Learn about Ampullary Cancer.
- Childhood Iron Deficiency AnemiaDr. Caffey isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Caffey isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Mountain SicknessDr. Caffey isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Caffey isExperienced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Caffey isExperienced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Appendix CancerDr. Caffey isExperienced. Learn about Appendix Cancer.
- Arterial EmbolismDr. Caffey isExperienced. Learn about Arterial Embolism.